Kilany, Lobna Abdel Aziz
Gaber, Ayman Abdel Samie
Aboulwafa, Mohammad Mabrouk
Zedan, Hamdallah Hafez
Article History
Received: 5 November 2020
Accepted: 3 February 2021
First Online: 19 February 2021
Ethics approval and consent to participate
: The present study was approved by The Institution Review Board (IRB) of National Cancer Institute (NCI) under the IRB No. IRB00004025. This approval was issued according to ICH-GCP guidelines. Signed informed consents were obtained from all patients whom their blood samples and clinical data were used in this study. Additionally another approval by the Safety and Occupational Health Committee at Faculty of Pharmacy, Cairo University, Cairo, Egypt with serial No. of MI (1481) has certify that this study doesn’t affect the health and safety. All methods involving animals use were carried out in compliance with the ARRIVE guidelines and approved by the Research Ethics Committee (REC) for experimental and clinical studies at Faculty of Pharmacy, Cairo University, Cairo, Egypt.
: N/A.
: The authors declare that they have no competing interests.